Supplement Industry Critics On Agenda For FDA's Ingredient List Meeting
This article was originally published in The Rose Sheet
Executive Summary
FDAs Oct. 3 meeting agenda includes Pieter Cohen, Harvard Medical School professor; Consumers Union Programs Director Chuck Bell; Laura MacCleery, Center for Science in the Public Interest regulatory affairs director; and Stephanie Scarmo, Pew Charitable Trusts Health Care Products Project officer.